Prevalence and Reclassification of Genetic Variants in South African Populations with Breast Cancer
Genes, Chromosomes and Cancer · 2024-09 · 63 (9)
DOI: 10.1002/gcc.23275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 26.09.2024. Verfasst von Tabitha S Osler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Breast Neoplasms, Black People. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Association of South Africa, Science for Africa Foundation.
Abstract (Originalsprache)
Concurrent testing of numerous genes for hereditary breast cancer (BC) is available but can result in management difficulties. We evaluated use of an expanded BC gene panel in women of diverse South African ancestries and assessed use of African genomic data to reclassify variants of uncertain significance (VUS). A total of 331 women of White, Black African, or Mixed Ancestry with BC had a 9‐gene panel test, with an additional 75 genes tested in those without a pathogenic/likely pathogenic (P/LP) variant. The proportion of VUS reclassified using ClinGen gene‐specific allele frequency (AF) thresholds or an AF > 0.001 in nonguidelines genes in African genomic data was determined. The 9‐gene panel identified 58 P/LP variants, but only two of the P/LP variants detected using the 75‐gene panel were in confirmed BC genes, resulting in a total of 60 (18.1%) in all participants. P/LP variant prevalence was similar across ancestry groups, but VUS prevalence was higher in Black African and Mixed Ancestry than in White participants. In total, 611 VUS were detected, representing 324 distinct variants. 10.8% (9/83) of VUS met ClinGen AF thresholds in genomic data while 10.8% (26/240) in nonguideline genes had an AF > 0.001. Overall, 27.0% of VUS occurrences could potentially be reclassified using African genomic data. Thus, expanding the gene panel yielded few clinically actionable variants but many VUS, particularly in participants of Black African and Mixed Ancestry. However, use of African genomic data has the potential to reclassify a significant proportion of VUS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Cape Town, Parow, South Africa.
- National Cancer Registry, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa.
- Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Cape Town, Parow, South Africa.
ORCID-Profile: Tabitha S Osler, Jean-Tristan Brandenburg, Mardelle Schoeman, Wenlong Carl Chen, Michael F Urban, Christopher G Mathew
Förderung
- Cancer Association of South Africa
- Science for Africa Foundation
Zitieren
APA
Osler, T. S., Brandenburg, J. T., Schoeman, M., Chen, W. C., Urban, M. F., & Mathew, C. G. (2024). Prevalence and Reclassification of Genetic Variants in South African Populations with Breast Cancer. Genes, Chromosomes and Cancer, 63(9). https://doi.org/10.1002/gcc.23275
Vancouver
Osler TS, Brandenburg JT, Schoeman M, Chen WC, Urban MF, Mathew CG. Prevalence and Reclassification of Genetic Variants in South African Populations with Breast Cancer. Genes, Chromosomes and Cancer. 2024;63(9). doi:10.1002/gcc.23275
BibTeX
@article{Osler2024,
author = {Osler, Tabitha S and Brandenburg, Jean-Tristan and Schoeman, Mardelle and Chen, Wenlong Carl and Urban, Michael F and Mathew, Christopher G},
title = {Prevalence and Reclassification of Genetic Variants in South African Populations with Breast Cancer},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
volume = {63},
number = {9},
doi = {10.1002/gcc.23275}
}
EUVIMED